Innovative Medicine
Backed by the Power of AI
BioXcel Therapeutics, Inc. is a
biopharmaceutical company developing transformative medicines in neuroscience utilizing artificial intelligence.
Innovative Medicine
Backed by the
Power of AI
BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.
Innovative Medicine
Backed by the Power of AI
BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.
Our Approach to Drug Development
- Optimizes R&D economics
- Shortens development timelines
- Increases probability of success

AI-Driven Transformative Medicines in Neuroscience
We utilize our unique and proprietary AI platform to identify, re-innovate, and develop potential new therapies

Aug 14, 2023
BioXcel Therapeutics Reports Second Quarter 2023 Financial Results and Announces Strategic ReprioritizationVIEW RELEASE
Jul 31, 2023
BioXcel Therapeutics to Report Second Quarter 2023 Financial Results on August 14, 2023VIEW RELEASE
Jun 29, 2023
BioXcel Therapeutics Announces Positive Topline Results From TRANQUILITY II Phase 3 Trial of BXCL501 for Acute Treatment of Alzheimer’s Disease-Related AgitationVIEW RELEASE
Stock Information
BioXcel Therapeutics, Inc.
Sep 20, 2023 04:00 PM
MARKET/SYMBOL
Nasdaq:
BTAI
PRICE
3.02
CHANGE
0 (0%)